Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:37:57.787Z.
Calculation as of: 2026-10-06T16:37:57.787Z.
Quote observation: 2026-10-06T16:35:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 880fb47a961da82dee7b372bf013e19f9356fddf046c7e26e64914405e113cb3
EARNINGS YIELD
N/A
Lexeo Therapeutics, Inc. Common Stock
Market Cap
$262.79M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.24M
Earnings Yield
N/A
TTM Avg
24.17%
3Y Avg
24.17%
5Y Avg
24.17%
Market Cap
$265.83M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.71M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.10M
Earnings Yield
N/A
TTM Avg
7.35%
3Y Avg
8.08%
5Y Avg
6.30%
Market Cap
$267.03M
Earnings Yield
N/A
TTM Avg
6.60%
3Y Avg
6.60%
5Y Avg
6.49%
Market Cap
$257.22M
Earnings Yield
N/A
TTM Avg
1.20%
3Y Avg
4.13%
5Y Avg
3.97%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. Common Stock (LXEO) | $262.79M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $261.24M | N/A | 24.17% | 24.17% | 24.17% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $265.83M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $266.71M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $260.03M | N/A | 8.07% | 8.07% | 7.35% |
| OraSure Technologies, Inc. (OSUR)vs › | $266.10M | N/A | 7.35% | 8.08% | 6.30% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.03M | N/A | 6.60% | 6.60% | 6.49% |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.22M | N/A | 1.20% | 4.13% | 3.97% |
| Scribe Therapeutics Inc. (SCTX)vs › | $270.48M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $273.53M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
